Us Bancorp \De\ Obs Eva Sa Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$2.56 - $3.35 $1,536 - $2,010	-600 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$2.01 - $5.05 $1,205 - $3,030	600 New	600 $2,000
Q4 2019 Feb 04, 2020	SELL	$2.48 - $8.1 $32,240 - $105,300	-13,000 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$10.0 - $17.87 $130,000 - $232,310	13,000 New	13,000 $197,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.